.jpg)
.jpg)
.jpg)
Recommended
Breaking News
FDA Approves Expanded Label for Iluvien to Include Chronic Noninfectious Uveitis
Mar 17, 2025
The FDA has approved an expanded label for Iluvien, allowing its use for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye, ANI Pharmaceuticals announced in a press release.
Atsena Therapeutics Receives FDA Fast Track Designation for ATSN-201 Gene Therapy in X-Linked Retinoschisis
Mar 13, 2025
Atsena Therapeutics has been granted Fast Track designation by the FDA for ATSN-201, its investigational gene therapy designed to treat X-linked retinoschisis (XLRS), a rare inherited retinal disease with no approved treatments.
Sydnexis Announces FDA Acceptance of NDA for SYD-101 in Pediatric Myopia Treatment
Mar 12, 2025
Sydnexis has reached a significant regulatory milestone with the FDA’s acceptance of its New Drug Application (NDA) for SYD-101, a potential first-in-class pharmaceutical treatment for the progression of pediatric myopia in the United States.
.jpg)
Industry News
Atsena Therapeutics Secures $150 Million Series C Funding to Advance Ocular Gene Therapy Pipeline
Apr 04, 2025
Atsena Therapeutics has successfully closed an oversubscribed $150 million Series C financing round to support the advancement of its gene therapy programs.
FDA Issues Complete Response Letter to Aldeyra Therapeutics for Reproxalap NDA Resubmission
Apr 04, 2025
The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Aldeyra Therapeutics, declining to approve the resubmitted New Drug Application (NDA) for reproxalap, the company’s investigational treatment for dry eye disease.
Prevent Blindness Declares April as Women’s Eye Health and Safety Month
Apr 03, 2025
Prevent Blindness, a leading nonprofit organization dedicated to eye health, has officially designated April as Women’s Eye Health and Safety Month.
Ophthalmic Research News
Five-Year Data Confirms Efficacy of Highly Aspherical Lenslets in Controlling Myopia Progression in Children
Apr 04, 2025
A newly published five-year clinical study has shown that spectacle lenses equipped with highly aspherical lenslets (HAL) can significantly slow both myopia progression and axial elongation in children.
Human Retinal Stem-Like Cells Discovered with Potential to Repair Vision Loss
Apr 03, 2025
A research team led by Wenzhou Medical University and collaborating institutions has identified a distinct population of human neural retinal stem-like cells with the ability to regenerate retinal tissue and support visual recovery.
NIH Researchers Demonstrate Promise of PEDF-Based Eye Drops for Inherited Retinal Diseases
Mar 24, 2025
A team at the National Eye Institute (NEI), part of the NIH, has developed and tested eye drops containing fragments of pigment epithelium-derived factor (PEDF)—a naturally occurring protein in the eye—to delay retinal degeneration in animal models.
Ophthalmic Blog
AI in Ophthalmology: Top Artificial Intelligence Tools Transforming Eye Health
Mar 07, 2025
The AI in ophthalmology sector is evolving rapidly, introducing Artificial Intelligence tools in ophthalmology that enhance diagnostic accuracy, efficiency, and accessibility.
2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies
Dec 23, 2024
The year 2024 has been a remarkable period for advancements in ophthalmology, with groundbreaking innovations reshaping the landscape of eye disease treatment and diagnosis.
2024 Recap: Top 8 FDA Approvals in Ophthalmology
Dec 16, 2024
The year 2024 has been a pivotal one for ophthalmology, with several novel FDA approvals introducing innovative treatments and technologies to the field
Ophthalmology Breaking News Subscribe